ZDHHC19 and endometrial carcinoma: Regarding chemokine receptors, ZDHHC19 displayed a generally positive correlation with chemokine receptors in most cancers, except for adrenocortical carcinoma, endometrial carcinoma, uterine sarcoma, and uveal melanoma, where it was negatively correlated with chemokine receptors (Figure 8d,e).